Literature DB >> 8847505

Mutations within conserved motifs in the 3'-5' exonuclease domain of herpes simplex virus DNA polymerase.

J D Hall1, K L Orth, K L Sander, B M Swihart, R A Senese.   

Abstract

We investigated mutations within the presumed 3'-5' exonuclease domain of the DNA polymerase from herpes simplex virus type 1. The mutation sites correspond to residues in DNA polymerase I (Escherichia coli) which bind two metal ions that are required for exonuclease function. To evaluate the effect of the herpesvirus mutations on enzymatic activity, we overexpressed the wild-type DNA polymerase and one mutant enzyme using a baculovirus expression system. Both proteins exhibited DNA polymerase activity after partial purification, but the mutant protein was drastically deficient in exonuclease activity. This finding suggests that the herpesvirus exonuclease may utilize the same metal-ion-mediated mechanism employed by DNA polymerase I. We also attempted to transfer each of the mutations into the herpesvirus genome using a marker rescue protocol. Although wild-type sequences could be transferred readily, recombinant viruses carrying mutant sequences were not recovered. We discuss the possibility that the mutations are lethal and suggest mechanisms by which a deficiency in 3'-5' exonuclease might cause loss of viability.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847505     DOI: 10.1099/0022-1317-76-12-2999

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Exonuclease-deficient polymerase mutant of herpes simplex virus type 1 induces altered spectra of mutations.

Authors:  Ying T Hwang; Charles B C Hwang
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  3' to 5' exonuclease activity of herpes simplex virus type 1 DNA polymerase modulates its strand displacement activity.

Authors:  Yali Zhu; Kelly S Trego; Liping Song; Deborah S Parris
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  Evidence that the nuclease activities associated with the herpes simplex type 1 DNA polymerase are due to the 3'-5' exonuclease.

Authors:  J D Hall; K L Orth; D Claus-Walker
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelity.

Authors:  Y T Hwang; B Y Liu; D M Coen; C B Hwang
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Herpes Simplex Virus 1 DNA Polymerase RNase H Activity Acts in a 3'-to-5' Direction and Is Dependent on the 3'-to-5' Exonuclease Active Site.

Authors:  Jessica L Lawler; Purba Mukherjee; Donald M Coen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  HSV-1 DNA polymerase 3'-5' exonuclease-deficient mutant D368A exhibits severely reduced viral DNA synthesis and polymerase expression.

Authors:  Jessica L Lawler; Donald M Coen
Journal:  J Gen Virol       Date:  2018-09-03       Impact factor: 3.891

7.  Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1.

Authors:  Wang Tian; Ying T Hwang; Qiangsheng Lu; Charles B C Hwang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

8.  Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.

Authors:  Sunwen Chou; Gail I Marousek
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  Mechanisms by which herpes simplex virus DNA polymerase limits translesion synthesis through abasic sites.

Authors:  Yali Zhu; Liping Song; Jason Stroud; Deborah S Parris
Journal:  DNA Repair (Amst)       Date:  2007-09-27

10.  Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.

Authors:  Julie Bestman-Smith; Guy Boivin
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.